Personalized Interactive Laser Therapy of Port Wine Stain
Personalized Interactive Laser Therapy of Port Wine Stain - Study 2
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Arkansas
-
Little Rock, Arkansas, United States, 72202
- Arkansas Children's Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosed with a PWS
- At least one visible PWS measuring greater than or equal to 15 mm in diameter.
- Information provided regarding alternative treatment methods, includig no treatment.
- Reading, understanding, and signing of an informed consent document.
- Children age 7 years or older has read, understood, and signed an assent document.
- Agreement to participate in the study.
- Agreement to return to at least 1 follow-up evaluation and treatment within 1 year after first treatment.
- Zubrod performance status of 0 or 1 at screening.
Exclusion Criteria:
- Inability or unwillingness of subject to participate in the study.
- Inability or unwillingness of one parent or legal guardian of the subject to sign written informed consent document.
- Subject can not return to at least 1 follow-up visit within 1 year, after the first treatment.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Average Laser Setting to be Used to Treat Port Wine Stains as Measured by Mathematical Calculations Based on Imaging and Temperature Analysis of Malformation.
Time Frame: Three treatments up to one year, whichever is first
|
6 subjects were enrolled but no data was ever collected due to early termination of the study due to the PI's relocation.
|
Three treatments up to one year, whichever is first
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Gal Shafirstein, PhD, UAMS, ACH
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 104344
- UAMS Sponsored
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.